Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model

Neuroscience Research

Volumn 75, Issue 4, 2013, Pages 324-330

  Abelaira, Helena M ^a   Réus, Gislaine Z ^a   Ribeiro, Karine F ^a   Steckert, Amanda V ^a   Mina, Francielle ^a   Rosa, Daniela V F ^b   Santana, Cíntia V ^b   Romano Silva, Marco Aurélio ^b   Dal Pizzol, Felipe ^a   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chronic mild stress; Depression; Lamotrigine; Oxidative stress; Signaling cascade

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; LAMOTRIGINE; MALONALDEHYDE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE B; SUCROSE; SUPEROXIDE DISMUTASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MALE; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUGAR INTAKE;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CATALASE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SUCROSE; SUPEROXIDE DISMUTASE; SWEETENING AGENTS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIAZINES;

EID: 84876102503     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.02.002     Document Type: Article

References (60)

1. Abelaira H.M., Réus G.Z., Ribeiro K.F., Zappellini G., Ferreira G.K., Gomes L.M., Carvalho-Silva M., Streck E.L., Luciano T.F., Marques S.O., Souza C.T., Quevedo J. Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats. Neurochem. Int. 2011, 59:1163-1174.
2. Agarwal N.B., Agarwal N.K., Mediratta P.K., Sharma K.K. Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure 2011, 20:257-262.
3. Arguello P.A., Gogos J.A. A signaling pathway AKTing up in schizophrenia. J. Clin. Invest. 2008, 118:2018-2021.
4. Arora T., Mehta A.K., Sharma K.K., Mediratta P.K., Banerjee B.D., Garg G.R., Sharma A.K. Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic Clin. Pharmacol. Toxicol. 2010, 106:372-377.
5. Bannister J.V., Calabrese L. Assays for superoxide dismutase. Methods Biochem. Anal. 1987, 32:279-312.
6. Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J. Biol. Chem. 2008, 281:32072-33280.
7. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001, 64:43-51.
8. Bowden C.L., Mitchell P., Suppes T. Lamotrigine in the treatment of bipolar depression. Eur. Neuropsychopharmacol. 1999, 9:113-117.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., Rudd G.D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J. Clin. Psychiatry 1999, 60:79-88.
11. Consoni F.T., Vital M.A., Andreatini R. Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur. Neuropsychopharmacol. 2006, 16:451-458.
12. D'Sa C., Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord. 2002, 4:183-194.
13. Della F.P., Abelaira H.M., Réus G.Z., Antunes A.R., Dos Santos M.A., Zappelinni G., Steckert A.V., Vuolo F., Galant L.S., Dal-Pizzol F., Kapczinski F., Quevedo J. Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model. Pharmacol. Biochem. Behav. 2012, 103:395-402.
14. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990, 186:421-431.
15. Duncan J.S., Thompson P.J. The cognitive consequences of epilepsy. Ann. Neurol. 2003, 54:421-422.
16. Fortunato J.J., Réus G.Z., Kirsch T.R., Stringari R.B., Fries G.R., Kapczinski F., Hallak J.E., Zuardi A.W., Crippa J.A., Quevedo J. Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Res. Bull. 2010, 81:491-496.
17. Frey B.N., Andreazza A.C., Ceresér K.M.M., Martins M.R., Valvassori S.S., Réus G.Z., Quevedo J., Kapczinski F. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci. 2006, 79:281-286.
18. Frick L.R., Rapanelli M., Arcos M.L., Cremaschi G.A., Genaro A.M. Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice. Eur. J. Pharmacol. 2011, 659:265-272.
19. Galecki P., Szemraj J., Bienkiewicz M., Florkowski A., Galecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol. Rep. 2009, 61:436-447.
20. Gamaro G.D., Manoli L.P., Torres I.L., Silveira R., Dalmaz C. Effects stress on feeding behavior and on monoamine levels in structures. Neurochem. Int. 2003, 42:107-114.
21. Garcia L.S.B., Comim C.M., Valvassori S.S., Réus G.Z., Stertz L., Kapczinski F., Gavioli E.C., Quevedo J. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 30:450-455.
22. Gold P., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 2002, 7:254-275.
23. Gronli J., Murison R., Fiske E., Bjorvatn B., Sorensen E., Portas C.M., et al. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol. Behav. 2005, 84:571-577.
24. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav. Brain Res. 2007, 18:42-51.
25. Huang Y.Y., Peng C.H., Yang Y.P., Wu C.C., Hsu W.M., Wang H.J., Chan K.H., Chou Y.P., Chen S.J., Chang Y.L. Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells. J. Pharmacol. Sci. 2007, 104:61-72.
26. Hurley S.C. Lamotrigine update and its use in mood disorders. Ann. Pharmacother. 2002, 36:860-873.
27. Jacobsen J.P.R., Mørkb A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 2006, 1110:221-225.
28. Jope R.S., Roh M.S. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 2006, 7:1421-1434.
29. Kaster M.P., Raupp I., Binfaré R.W., Andreatini R., Rodrigues A.L. Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur. J. Pharmacol. 2007, 565:119-124.
30. Katz R.J., Roth K.A., Carroll B.J. Animal models and human depressive disorders. Neurosci. Biobehav. Rev. 1981, 5:231-246.
31. Konkle A.T.M., Baker S.L., Kentner A.C., Barbagallo L.S.M., Merali Z., Bielajew C. Evaluation of the effects of chronic mild stressors on hedonic and physiological responses: sex and strain compared. Brain Res. 2003, 992:227-238.
32. Kosten T.A., Gallowaym M.P., Duman R.S., Russell D.S., D'Sa C. Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008, 33:1545-1558.
33. Kotan V.O., Sarandol E., Kirhan E., Ozkaya G. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog. Neuropsychopharmacol. Biol. Psychiatry 1991, 35:1284-1290.
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
35. Lawlor M., Alessi D. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J. Cell Sci. 2001, 114:2903-2910.
36. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994, 233:346-357.
37. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 1999, 4:317-327.
38. Liu D., Thangnipon W., McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 1991, 547:344-348.
39. Llyod C. Life events and depressive disorder reviewed II. Events as precipitating factors. Arch. Gen. Psychiatry 1980, 37:541-548.
40. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
41. Lucassen P.J., Vollmann-Honsdorf G.K., Gleisberg M., Czéh B., De Kloet E.R., Fuchs E. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur. J. Neurosci. 2001, 14:161-166.
42. Lucca G., Comim C.M., Valvassori S.S., Pereira J.G., Stertz L., Gavioli E.C., Kapczinski F., Quevedo J. Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels. Curr. Neurovasc. Res. 2008, 5:207-213.
43. Lucca G., Comim C.M., Valvassori S.S., Réus G.Z., Vuolo F., Petronilho F., Dal-Pizzol F., Gavioli E.C., Quevedo J. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem. Int. 2008, 54:358-362.
44. Martinez-Ballesteros C., Pita-Calandre E., Sanch-Gonzalez Y., Rodriguez-Lopez C.M., Agil A. Lipid peroxidation in adult patients treated with valproic acid. Rev. Neurol. 2004, 38:101-106.
45. Mikulecká A., Kubová H., Mares P. Lamotrigine does not impair motor performance and spontaneous behavior in developing rats. Epilepsy Behav. 2004, 4:464-471.
46. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
47. Murray F., Hutson P.H. Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists. Eur. J. Pharmacol. 2007, 569:41-47.
48. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviors in mice. Eur. J. Pharmacol. 2008, 583:115-127.
49. Musazzi L., Treccani G., Mallei A., Popoli M. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol. Psychiatry 2012, 10.1016/j.biopsych.2012.11.009.
50. Pardon M.C., Gerardin P., Joubert C., Perez-Diaz F., Cohen-Salmon C. Influence of prepartum chronic ultramild stress on maternal care behavior in mice. Biol. Psychiatry 2000, 47:858-863.
51. Pavone A., Cardile V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 2003, 4:34-39.
52. Paxinos G., Watson C. The Rat Brain: Stereotaxic Coordinates 1986, Academic Press, Australia. second ed.
53. Peng C.H., Chiou S.H., Chen S.J., Chou Y.C., Ku H.H., Cheng C.K., Yen C.J., Tsai T.H., Chang Y.L., Kao C.L. Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur. Neuropsychopharmacol. 2008, 18:128-140.
54. Sejima H., Ito M., Kishi K., Tsuda H., Shiraishi H. Regional excitatory and inhibitory amino acid concentrations in pentylenetetrazole kindling and kindled rat brain. Brain Dev. 1997, 19:171-175.
55. Stanton P.K., Moskal J.R. Diphenylhydantoin protects against hypoxia induced impairment of hippocampal synaptic transmission. Brain Res. 1991, 546:351-354.
56. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 239:44-84.
57. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl.) 1997, 134:319-329.
58. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
59. Willnera P., Mitchell P.J. The validity of animal models of predisposition to depression. Behav. Pharmacol. 2002, 13:169-188.
60. Wolkowitz O.M., Epel E.S., Mellon S. When blue turns grey: do stress and depression accelerate cell aging?. World J. Biol. Psychiatry 2008, 9:2-5.